Use of the LLC Holding Company Structure by Life Sciences Companies

Use of the LLC Holding Company Structure by Life Sciences Companies

Publication

Related Documents

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
Life sciences companies (particularly early stage companies) may be attracted to an LLC holding company structure as an alternative to a typical C corporation structure to maximize both the purchase price paid by a future acquiror of a drug development program and the after-tax proceeds realized by the company’s investors upon a sale. View a description of the LLC holding company structure and its pros and cons. For further questions, reach out to either Bill Caporizzo or Meghan Walsh in WilmerHale’s Tax Practice or Stuart Falber in WilmerHale’s Life Sciences Group.

Authors

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel